BMO Capital analyst Jack Matten raised the firm’s price target on Globe Life (GL) to $149 from $114 and keeps a Market Perform rating on the shares after its Q2 results. The firm cites the company’s positive underlying trends at its Direct to Consumer arm which helps exclusive agency sales via leads+analytics, along with the removal of a valuation overhang from inquiries and investigations, the analyst tells investors in a research note. The stock’s valuation also still embeds some discount versus long-term averages, BMO added.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
- Positive Regulatory Outcomes Reinforce Buy Rating for Globe Life
- Globe Life price target raised to $160 from $155 at Keefe Bruyette
- Early notable gainers among liquid option names on July 29th
- Globe Life Cleared by DOJ and SEC Investigations
- Globe Life announces closing of Department of Justice investigation